Malignancy that develops after kidney transplantation is a serious complication. The incidence is three to five times higher in comparison to that of the general population. Solid organ transplant patients have a higher incidence in plasma cell neoplasms what could significantly worsen allograft survival. The novelty of this report is that an example of diagnosis and treatment of ALamyloidosis and multiple myeloma verified after kidney transplantation is presented.
No takes yet. Share an insight, caveat, or question.
Komissarov et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: